Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

NERVGEN PHARMA CORP (NGENF)

0 + Investors. Track Smart Money conviction in NGENF. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
→ 0
Streak
1Q —
Buyers last Q
50%

Smart Money Signals — NGENF

Based on 1 hedge funds · latest filing: 2024 Q1 · updated quarterly

➡️

No change last quarter

last 6Q
The number of hedge funds holding this stock didn't change last quarter. Neither a buying nor selling signal on its own — watch the next quarter for direction.
🔻

Below peak — only 50% of 3.0Y high

50% of all-time peak
Only 1 funds hold NGENF today versus a peak of 2 funds at 2021 Q4 — just 50% of the maximum. Low institutional ownership can mean the stock is out of favor, but it also means there's a large pool of potential buyers if sentiment turns.
〰️

Stable — ownership unchanged year-over-year

fund count last 6Q
The number of hedge funds holding NGENF is almost the same as a year ago (+0 funds, +0% change). No significant rush to buy or sell — institutional backing is holding steady.
🟡

Slight buying edge — 50% buying

0 buying0 selling
Last quarter: 0 funds bought or added vs 0 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
➡️

Steady new buyers — ~0 new funds per quarter

Funds opening this position for the first time: 0 → 0 → 0 → 0. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
💎

Buying through price weakness — shares +0%, value -17%

Value
-16%
Shares
+0%
Last quarter: funds added +0% more shares while total portfolio value only changed -17%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
➡️

Steady discovery — ~0 new funds/quarter

New funds entering each quarter: 0 → 0 → 0 → 0. Consistent flow of new institutional buyers without clear acceleration or slowdown.
1.0
out of 10
Low Exit Risk
Exit risk score 1.0/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — NGENF

In 2024 Q1, 0 hedge funds were net buyers of NGENF, while 0 reduced or exited — a 50% buyer ratio, indicating a slight buying edge. Net fund flow last quarter: flat (entries and exits balanced). Total institutional holders: 1.

Hedge Fund Ownership: NGENF

How many hedge funds hold NGENF — quarterly history vs. share price
Quarterly hedge fund ownership of NGENF vs. share price

Market Analysis: NGENF

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: NGENF

Healthcare Biotechnology

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

0 top-rated funds 0 high-conviction
Consensus
0.0
/ 10
breadth
×
Elite
0.0
/ 10
conviction
Hedge Fund Positioning: NGENF
2026 Q1 Stats Unlock in 9 days 0 + Investors

Track Smart Money conviction in NGENF. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2025 Q4) Prior (2025 Q3) Change
Funds Holding 0 0 -
13F Shares 0 0 -
Total Value $0 $0 -
New Positions 0 0 -
Increased Positions 0 0 -
Closed Positions 0 0 -
Reduced Positions 0 0 -
Total Calls 0 0 -
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: NGENF

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

0 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in NGENF. Verified SEC 13F-HR filings.

Top 17 institutional holders of NGENF — 2025 Q4 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 VALLEY FORGE INVESTMENT CONSULTANTS INC ADV 0.09% 77,698 $293K
2 PFG Investments, LLC 0.04% 201,000 $758K
3 Almanack Investment Partners, LLC. 0.01% 20,925 $79K
4 Aventura Private Wealth, LLC 0.01% 6,880 $26K
5 Patriot Financial Group Insurance Agency, LLC 0.01% 37,000 $139K
6 McKinley Carter Wealth Services, Inc. 0.01% 30,892 $116K
7 D'Orazio & Associates, Inc. 0.00% 10,000 $38K
8 SPROTT INC. 0.00% 25,000 $94K
9 Busey Bank 0.00% 25,000 $94K
10 Ashton Thomas Private Wealth, LLC 0.00% 10,700 $40K
11 FLPUTNAM INVESTMENT MANAGEMENT CO 0.00% 10,200 $38K
12 COMMONWEALTH EQUITY SERVICES, LLC 0.00% 33,350 $126K
13 Steward Partners Investment Advisory, LLC 0.00% 4,103 $15K
14 UBS Group AG 0.00% 61,517 $232K
15 ENVESTNET ASSET MANAGEMENT INC 0.00% 20,000 $75K
16 LPL Financial LLC 0.00% 13,400 $51K
17 Caitong International Asset Management Co., Ltd 0.00% 1 —
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — NERVGEN PHARMA CORP (NGENF)

What does the Smart Money Trend signal show for NGENF?

No change last quarter: The number of hedge funds holding this stock didn't change last quarter. Neither a buying nor selling signal on its own — watch the next quarter for direction.

What is the institutional breadth score for NGENF?

Slight buying edge — 50% buying: Last quarter: 0 funds bought or added vs 0 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.